Structure Therapeutics Inc. — Director's Dealing 2023

Feb 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-07

Reporting Person: Bach Mark Allen (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-07	American Depositary Shares	$	P	1500	Acquired		Ordinary Shares (4500)	Direct

Footnotes

F1: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F2: The American Depositary Shares were purchased in the Issuer's initial public offering.